Logo
Login

Company Executives

$ Management Team

Mr. Mark Mckenna

Independent Chairman of the Board

Age 45
Compensation $4.110M USD
Sex Male

Dr. Michael Henderson

Chief Executive Officer

Director

Age 35
Compensation $13.21M USD
Sex Male

Ms. Jane Henderson

Chief Financial Officer

Age 59
Compensation $5.080M USD
Sex Female

Mr. Carl Dambkowski

Chief Medical Officer

Age 40
Compensation $5.080M USD
Sex Male

Board of Directors

From the proxy statement filed Apr 24, 2026
Directors
9
serving now
Independent
8 of 9
stated in the proxy
Average tenure
2.9 years
from year joined
CEO also chairs the board
No
Mark C. McKenna
Director Age On board Independent Committees Other public boards 2025 pay Source
Mark C. McKenna
Board chair
 46 2023
3 years
 Independent None stated Spyre Therapeutics, Inc. $487,219
Jennifer Fox
54 2023
3 years
 Independent None stated ProKidney Corp. $464,026
William (BJ) Jones, Jr.
62 2023
3 years
 Independent None stated Annexon Biosciences $455,411
Michael Henderson, M.D.
CEO
 36 2023
3 years
 Not independent None stated Spyre Therapeutics Paid as CEO
Lisa Bollinger, M.D.
61 2024
2 years
 Independent None stated None stated $444,526
Tomas Kiselak
39 2023
3 years
 Independent None stated Viridian Therapeutics, Inc. $439,988
Nimish Shah
48 2023
3 years
 Independent None stated None stated $444,526
Andrew Gottesdiener, M.D. Leaving at the meeting
Not stated Not stated Independent None stated None stated $448,834
Peter Harwin Leaving at the meeting
Not stated Not stated Independent None stated None stated $448,834

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

Related-party transactions

No related-party transactions disclosed

The proxy filed Apr 24, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans